COVID19 vaccine trials in Australia was a main discussion point during today’s Medicine Australia’s PharmAus20 conference.
Rather than the traditional timeframe being linear and staged, COVID trials use an accelerated timeframe which is condensed and stacked ie clinical phases run concurrently; manufacturing is scaled without certainty; and regulatory and distribution plans expedited.
Australia has been actively involved in COVID vaccine trials. There’s been 3 trials: with first doses administered 26 May, 13 July and 1 September, with numerous other vaccine/therapy trials planned. Although timelines are fast no important steps are missed.
Australia is an attractive place to undertake clinical research because of our excellent healthcare system; well-coordinated delivery of care; established clinical trial networks; and the infrastructure to further build expertise & capability. Best practice includes the embedding of clinical trials into standard clinical practice and increasing consumer involvement and engagement in clinical trials.
Thank you to the speakers: Elizabeth de Somer, Lorraine Chiroiu, John Zalcberg, Paul Griffin, Dominic Wall and Robert Grenfell